Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Abbott HbA1c Test FDA Cleared to Diagnose Diabetes

Abbott HbA1c Test FDA Cleared to Diagnose Diabetes

Jun 21, 2018
|
staff reporter

NEW YORK (360Dx) – Abbott said on Thursday that the US Food and Drug Administration has cleared the company's Afinion HbA1c Dx assay to help diagnose diabetes mellitus and assess a patient's risk of developing the disease.

The rapid point-of-care assay was cleared to run on Abbott's Afinion AS100 Analyzer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC

  2. Credo Diagnostics Combo Influenza, COVID-19 Test Receives CE-IVD Mark

  3. DiaSorin High-Throughput, Rapid Antigen SARS-CoV-2 Test Gets CE Mark

  4. Ortho Clinical Diagnostics Gets CE Mark for High-Throughput SARS-CoV-2 Antigen Test

  5. Agena Bioscience Gets FDA Emergency Use Authorization for MassArray Coronavirus Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.